PhRMA reports record number of rare disease drug candidates under development
28 February 2011
Donna Young
Please Login to read the full article.
28 February 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- Focus on Almirall: partnering, new products and mature markets are key targets
- European generics firms, squeezed between innovators and payers, seek diversity
- Genzyme yet to confirm date of next Fabrazyme shipment
FEATURES
Other Informa Features
